Hegedus Z L, Frank H A, Steinman T I, Nayak U
Department of Surgery, Beth Israel Hospital, Boston, MA.
Arch Int Physiol Biochim Biophys. 1991 Aug;99(4):355-63. doi: 10.3109/13813459109146950.
Fluorescence spectrophotometry demonstrates that the levels of plasma soluble lipofuscins (SL) in patients with end-stage renal failure, undergoing continuous ambulatory peritoneal dialysis (CAPD) or haemodialysis (HD), remain significantly higher than in normal subjects. Plasma samples from these patients show the presence of SL generated from 3-hydroxy-anthranilic acid [excitation (ex) at approximately 324 nm and emission (em) at approximately 413 nm] and of other SL generated from dopa, catecholamines, 3-hydroxykynurenine and from structurally related precursors (ex at approximately 345 nm, em at approximately 445 nm). These precursors form the melanin components, which are approximately 3 wt % of SL. The fluorescence of SL appears to originate mainly from the melanin components. Peaks and shoulders at these wavelengths are found in the spectra of all dialysates. Based on intensity measurements at 413 nm and 445 nm, the weekly clearance rates with HD are in general greater than those with CAPD. The saponified cellulose ester membrane used in HD passes only lower-molecular-weight SL and/or components of SL. After HD, the greatest reductions in plasma intensities are found at approximately 324 nm and approximately 413 nm. The clearance rates (l/week) are always greater at 413 nm [means HD: 18.47 +/- 4.44 standard deviation (SD), n = 8; CAPD: 12.50 +/- 2.47, n = 4] than at 445 nm (HD: 10.94 +/- 3.86; CAPD: 7.95 +/- 1.75) both with HD and CAPD. In CAPD, the membrane also permits the passage of large amounts of albumin and other high-molecular-weight substances.(ABSTRACT TRUNCATED AT 250 WORDS)
荧光分光光度法表明,接受持续非卧床腹膜透析(CAPD)或血液透析(HD)的终末期肾衰竭患者血浆可溶性脂褐素(SL)水平仍显著高于正常受试者。这些患者的血浆样本显示存在由3-羟基邻氨基苯甲酸产生的SL[激发(ex)约为324nm,发射(em)约为413nm]以及由多巴、儿茶酚胺、3-羟基犬尿氨酸和结构相关前体产生的其他SL(ex约为345nm,em约为445nm)。这些前体形成黑色素成分,约占SL的3wt%。SL的荧光似乎主要源自黑色素成分。在所有透析液的光谱中都能发现这些波长处的峰和肩。基于在413nm和445nm处的强度测量,HD的每周清除率总体上高于CAPD。HD中使用的皂化纤维素酯膜仅能通过低分子量的SL和/或SL的成分。HD后,血浆强度在约324nm和约413nm处的降低最为显著。无论是HD还是CAPD,413nm处的清除率(升/周)总是高于445nm处(HD:18.47±4.44标准差(SD),n = 8;CAPD:12.50±2.47,n = 4)(HD:10.94±3.86;CAPD:7.95±1.75)。在CAPD中,该膜还允许大量白蛋白和其他高分子量物质通过。(摘要截短至250字)